P-133 Subcutaneous furosemide use in the community setting: clinical benefit and hospital avoidance | BMJ Supportive & Palliative Care

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Poster Presentations

Resourcing palliative care

P-133 Subcutaneous furosemide use in the community setting: clinical benefit and hospital avoidance

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Jackson I, Burmeister B, Hodson F

P-133 Subcutaneous furosemide use in the community setting: clinical benefit and hospital avoidance

BMJ Supportive & Palliative Care 2021;11:A57.